retinopathy glp 1 PDF] GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe? GLP-1 Agonists Can Reduce BRVO

This is a secondary mechanism, but clinically relevant

It also has many drivers, so one gut fix rarely works for everyone

A good provider will slow things down, look at labs, talk through risks and benefits in plain English, and tailor dosing to real goals instead of pushing everyone down the same path

What nutritionists have to guard against are the common problems of dehydration and low blood pressure, which can lead to kidney problems

Watch-outs to know: Emideltide is often stacked with other peptides, but these combinations are also unstudied

Agree that this likely signals the beginning of a broader small-molecule GLP-1 era